A British trial of the AstraZeneca coronavirus vaccine on children has been paused, Oxford University said Tuesday, as global regulators rush to assess its possible link to rare blood clots in adults, AFP reports.
The university, which helped develop the vaccine, said in a statement quoted by the news agency that there were "no safety concerns" in the trial, but acknowledged fears over a potential link to clots by saying that it was awaiting additional data from Britain's Medicines and Healthcare products Regulatory Agency (MHRA) before restarting the study.
Read more